<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>A combination therapy of ingredients from TCM for the prevention and treatment of gastric cancer by targeting HER2/ PD-L1</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Ling</namePart>
      <namePart type="family">Li</namePart>
      <displayForm>Li, Ling</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jia-wei</namePart>
      <namePart type="family">Li</namePart>
      <displayForm>Li, Jia-wei</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <affiliation>Preclinical Medicine School, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Xiao-jie</namePart>
      <namePart type="family">Jin</namePart>
      <displayForm>Jin, Xiao-jie</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <affiliation>College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Cheng-hao</namePart>
      <namePart type="family">Li</namePart>
      <displayForm>Li, Cheng-hao</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jun-jie</namePart>
      <namePart type="family">Li</namePart>
      <displayForm>Li, Jun-jie</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Ming</namePart>
      <namePart type="family">Fang</namePart>
      <displayForm>Fang, Ming</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <affiliation>Preclinical Medicine School, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Lu</namePart>
      <namePart type="family">Qiu</namePart>
      <displayForm>Qiu, Lu</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Si-yu</namePart>
      <namePart type="family">Wang</namePart>
      <displayForm>Wang, Si-yu</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Wei</namePart>
      <namePart type="family">Chu</namePart>
      <displayForm>Chu, Wei</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Yong-qi</namePart>
      <namePart type="family">Liu</namePart>
      <displayForm>Liu, Yong-qi</displayForm>
      <affiliation>Gansu University Key Laboratory for Molecular Medicine &amp; Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou, China</affiliation>
      <affiliation>Key Laboratory of Dun huang Medicine, Ministry of Education, Lanzhou, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2021-12</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>Gastric cancer (GC) is a globally important disease. Targeted therapies licensed to treat gastric cancer include trastuzumab, which targets HER2, and nivolumab or pembrolizumab, which block PD-1/PD-L1. The main challenge of tumor molecule-targeted drugs is resistance. Based on the multicomponent and multitarget characteristics of Traditional Chinese Medicine (TCM) and our previous research on Guiqi Baizhu Prescription (GQBZP) in targeting HER2/PD-L1, we used different cell models to verify the effect of quercetin targeting of HER2 and formononetin targeting of PD-L1. The results show that quercetin can inhibit MKN-45 cell proliferation by targeting HER2 to inhibit the PI3K-AKT pathway, and formononetin can regulate T-cell function by inhibiting the PD-1/PD-L1 pathway. We also used GC MKN-45 cells in a T lymphocyte co-culture model to show that quercetin and formononetin co-treatment can regulate T cell function and inhibit MKN-45 cell proliferation. More importantly, quercetin with formononetin treatment had a greater effect than treatment with either quercetin or formononetin alone. We believe that quercetin and formononetin may be useful to target HER2 and inhibit PD-1/PD-L1 in GC. </abstract>
   <subject>
      <topic>Gastric cancer</topic>
   </subject>
   <subject>
      <topic>HER2/PD-L1</topic>
   </subject>
   <subject>
      <topic>combined treatment</topic>
   </subject>
   <subject>
      <topic>traditional Chinese medicine</topic>
   </subject>
   <subject>
      <topic>quercetin/formononetin</topic>
   </subject>
   <subject>
      <topic>EGF</topic>
   </subject>
   <subject>
      <topic>GC</topic>
   </subject>
   <subject>
      <topic>GQBZP</topic>
   </subject>
   <subject>
      <topic>HER2</topic>
   </subject>
   <subject>
      <topic>IFN-γ</topic>
   </subject>
   <subject>
      <topic>IL-2</topic>
   </subject>
   <subject>
      <topic>PBMCs</topic>
   </subject>
   <subject>
      <topic>PD-1</topic>
   </subject>
   <subject>
      <topic>PD-L1</topic>
   </subject>
   <subject>
      <topic>TCM</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Pharmacological Research - Modern Chinese Medicine</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier B.V.</publisher>
      </originInfo>
      <identifier type="issn">2667-1425</identifier>
      <part>
         <detail type="volume">
            <number>1</number>
            <caption>v.</caption>
         </detail>
         <text type="display-date">December 2021</text>
         <text type="year">2021</text>
         <text type="month">December</text>
         <extent unit="pages">
            <start>100021</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.prmcm.2021.100021</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.prmcm.2021.100021</url>
   </location>
   <identifier type="pii">S2667-1425(21)00020-8</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY-NC-ND 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2021-11-21"/>
         <licence_ref>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/164128545923847224-00001/2667-1425/S2667142521X00024/S2667142521000208/S2667142521000208.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
